The map provides a state-by-state breakdown of the nation’s hepatitis C epidemic. Approximately 3.9 million Americans carry hepatitis C antibodies, which are indicative of either past or current infections.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox
“HepVu empowers hepatitis advocates, state health departments, and policy makers to use data-driven tools to push for better programs to provide testing, care and treatment for HCV for people in need of these services across the nation,” said Patrick Sullivan, PhD, professor of epidemiology at Emory and principal scientist for HepVu. “By mapping the epidemic, HepVu helps us understand which states are most impacted by Hepatitis C, and where we need to focus our screening and treatment resources.”
To learn more about hepatitis C, click here.
More articles on infection control:
Chicago health department offers families free whooping cough vaccine
Researchers create synthetic mucus to ward off infections
Strep strain shows newly detected signs of antibiotic resistance, study shows
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
